Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Revamilast (GRC-4039) / Glenmark

NCT01430507 / 2011-000107-40: A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Completed

406

Europe, RoW

Revamilast, Placebo Comparator

Glenmark Pharmaceuticals Ltd. India, Glenmark Pharmaceuticals S.A.

Rheumatoid Arthritis

12/12

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites